Immersion prime and oral boost vaccination with an inactivated Vibrio harveyi vaccine confers a specific immune response and protection in Asian seabass (Lates calcarifer)

被引:3
|
作者
Lan, Nguyen Giang Thu [1 ]
Dong, Ha Thanh [3 ,7 ]
Vinh, Nguyen Tien [3 ]
Senapin, Saengchan [4 ,5 ]
Shinn, Andrew P. [6 ]
Salin, Krishna R. [3 ]
Rodkhum, Channarong [1 ,2 ,8 ]
机构
[1] Chulalongkorn Univ, Fac Vet Sci, Int Grad Program Vet Sci & Technol VST, Bangkok, Thailand
[2] Chulalongkorn Univ, Fac Vet Sci, Ctr Excellence Fish Infect Dis CE FID, Dept Vet Microbiol, Bangkok, Thailand
[3] Asian Inst Technol, Sch Environm Resources & Dev, Dept Food Agr & Bioresources, Aquaculture & Aquat Resources Management, Pathum Thani, Thailand
[4] Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand
[5] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Centex, Fish Heath Platform, Bangkok, Thailand
[6] INVE Thailand, 471 Bond St, Pakkred 11120, Nonthaburi, Thailand
[7] Asian Inst Technol, Pathum Thani, Thailand
[8] Chulalongkorn Univ, Bangkok, Thailand
关键词
Asian seabass; Lates calcarifer; Vibrio harveyi; Vaccines; Immersion prime; Oral booster; Antibody response; STREPTOCOCCUS-INIAE; ANTIGEN UPTAKE; DNA VACCINE; SCALE DROP; BARRAMUNDI; DISEASE; FISH; BLOCH;
D O I
10.1016/j.fsi.2023.109293
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Asian seabass (Lates calcarifer) holds significant economic value in fish farming in the Asia-Pacific region. Vibriosis caused by Vibrio harveyi (Vh) is a severe infectious disease affecting intensive farming of this species, for which prevention strategies by vaccination have been developed. This study investigated an alternative approach to injectable vaccination to prevent vibriosis in Asian seabass juveniles. The strategy begins with an immersion prime vaccination with a heat-inactivated Vh vaccine, followed by two oral booster doses administered at 14-and 28-days post-vaccination (dpv). Expression of five immune genes TNF alpha, IL1 beta, CD4, CD8, and IgM in the head kidney and spleen, along with investigation of anti-Vh antibody response (IgM) in both systemic and mucosal systems, was conducted on a weekly basis. The efficacy of the vaccines was assessed by a laboratory challenge test at 43 dpv. The results showed that the immunized fish displayed higher levels of mRNA transcripts of the immune genes after the immersion prime and the first oral booster dose compared to the control group. The expression levels peaked at 14 and 28 dpv and then declined to baseline at 35 and 42 dpv. Serum specific IgM antibodies were detected as early as 7 dpv (the first time point investigated) and exhibited a steady increase, reaching the first peak at 21 dpv, and a second peak at 35 dpv. Although the antibody levels gradually declined over subsequent weeks, they remained significantly higher than the control group throughout the experiment. A similar antibody response pattern was also observed in the mucosal compartment. The laboratory challenge test demonstrated high protection by injection with 1.65 x 104 CFU/fish, with a relative percent of survival (RPS) of 72.22 +/- 7.86 %. In conclusion, our findings highlight the potential of an immersion prime-oral booster vaccination strategy as a promising approach for preventing vibriosis in Asian seabass.
引用
收藏
页数:11
相关论文
共 25 条
  • [21] Vaccination effect of liposomes entrapped whole cell bacterial vaccine on immune response and disease protection in Epinephelus bruneus against Vibrio harveyi
    Harikrishnan, Ramasamy
    Kim, Ju-Sang
    Balasundaram, Chellam
    Heo, Moon-Soo
    AQUACULTURE, 2012, 342 : 69 - 74
  • [22] Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response
    Ramos, I.
    Alonso, A.
    Marcen, J. M.
    Peris, A.
    Castillo, J. A.
    Colmenares, M.
    Larraga, V.
    VACCINE, 2008, 26 (03) : 333 - 344
  • [23] Enhanced immune response by amphotericin B following NS 1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge
    Liu, Wen-Tssann
    Lin, Wei-Ting
    Tsai, Chung-Chin
    Chuang, ChuanChang
    Liao, Chin-Len
    Lin, Huang-Chi
    Hung, Yao-Wen
    Huang, Shih-Shiung
    Liang, Chung-Chih
    Hsu, Hui-Ling
    Wang, Hsian-Jenn
    Liu, Yu-Tien
    VACCINE, 2006, 24 (31-32) : 5852 - 5861
  • [24] IMMUNE RESPONSES AGAINST O-SPECIFIC POLYSACCHARIDE (OSP) DEVELOP AFTER VACCINATION WITH ORAL CHOLERA VACCINE CVD 103-HGR (VAXCHORA) AND THESE RESPONSES ARE ASSOCIATED WITH PROTECTION AGAINST EXPERIMENTAL INFECTION WITH VIBRIO CHOLERAE O1 EL TOR INABA IN NORTH AMERICAN VOLUNTEERS
    Islam, Kamrul
    Kelly, Meagan
    Smith, Leslie Mayo
    Charles, Richelle
    Bhuiyan, Taufiqur R.
    Kovac, Pavol
    Xu, Peng
    LaRocque, Regina
    Calderwood, Stephen
    Simon, J. K.
    Chen, W. H.
    Haney, D.
    Lock, M.
    Lyon, C. E.
    Kirkpatrick, B. D.
    Cohen, M.
    Levine, M. M.
    Gurwith, M.
    Harris, Jason B.
    Qadri, Firdausi
    Ryan, Edward T.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 605 - 605
  • [25] Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 EI Tor Inaba in North American volunteers
    Islam, Kamrul
    Hossain, Motaher
    Kelly, Meagan
    Smith, Leslie M. Mayo
    Charles, Richelle C.
    Bhuiyan, Taufiqur Rahman
    Kovac, Pavol
    Xu, Peng
    LaRocque, Regina C.
    Calderwood, Stephen B.
    Simon, Jakub K.
    Chen, Wilbur H.
    Haney, Douglas
    Lock, Michael
    Lyon, Caroline E.
    Kirkpatrick, Beth D.
    Cohen, Mitchell
    Levine, Myron M.
    Gurwith, Marc
    Harris, Jason B.
    Qadri, Firdausi
    Ryan, Edward T.
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (04):